[Screening of bioactive metabolites that suppress inflammation].
Umezawa
Kazuo
K
umezawa@applc.keio.ac.jp
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D001688:Biological Products / Q000737:chemistry; D002454:Cell Differentiation / Q000187:drug effects; D003512:Cyclohexanones / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D047630:Depsipeptides / Q000302:isolation & purification / Q000494:pharmacology; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology*; D018836:Inflammation Mediators / Q000502:physiology; D008070:Lipopolysaccharides / Q000378:metabolism; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology; D010010:Osteoclasts / Q000166:cytology; D010881:Piperidones / Q000302:isolation & purification / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology
D000893:Anti-Inflammatory Agents; D001549:Benzamides; D001688:Biological Products; D003512:Cyclohexanones; D047630:Depsipeptides; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D016328:NF-kappa B; D010881:Piperidones; C464444:dehydroxymethylepoxyquinomicin; C496213:heptadepsin, Paenibacillus; C008497:9-methylstreptimidone